Clinical Trials Browser

Phase 2 × Gastro-enteropancreatic neuroendocrine tumor × Cisplatin × Clear all

NCT03963193 2019-05-24

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Phase 2 Unknown

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor